Announcements Trials
Browse Landscape

Status

Recruiting 1Completed 1

Sponsor Class

INDUSTRY 2

Study Type

Interventional 12Observational 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Urinary Bladder Neoplasms 2Non-Muscle Invasive Bladder Neoplasms 1Neoplasms 1

Interventions

Surveys and Questionnaires 9Cystectomy 6Blood Specimen Collection 5Neoadjuvant Therapy 4Cystoscopy 4Drug Therapy 3avelumab 2Urination 2Urinary Diversion 2Surgical Procedures, Operative 2Radiotherapy 2Pioglitazone 2Microarray Analysis 2Methods 2Magnetic Resonance Spectroscopy 2Interviews as Topic 2Immunohistochemistry 2Defecation 2Biopsy 25-aminolevulinic acid hexyl ester 2trastuzumab deruxtecan 1sargramostim 1pembrolizumab 1erdafitinib 1enfortumab vedotin 1acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 1Watchful Waiting 1Urinary Sediment Analysis 1Therapeutics 1Specimen Handling 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Observational × Urinary Bladder Neoplasms × 5-aminolevulinic acid hexyl ester × Clear all
NCT02660645 2025-12-18

BLCCR

Photocure

Recruiting
4,400 enrolled
Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

NCT00634621 2014-08-25

Effectiveness of Hexaminolevulinate (Hexvix) in the Diagnosis and Treatment of Patients With Non-invasive Bladder Cancer

GE Healthcare

Completed
283 enrolled 6 charts
Genitourinary

Urinary Bladder Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡